A Phase 4 interventional study of NSAID and Opioid in Surgery and Pain, Postoperative, sponsored by University of Michigan. Recruiting at 8 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.
Sponsored by University of Michigan · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 5th largest by planned enrollment, is one of 11 that started in 2023, is one of 84 in phase 4, reaches primary completion later than 13 of the 24 other live ones, and was the 189th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:
Moumtzidou Maria Aikaterini · Sites in Greece
Ages 18+ · Women only
Northwestern University · Sites in United States
Ages 18–80
University of Puerto Rico · Sites in Puerto Rico
Ages 21–65
Jessica D. Kresowik · Sites in United States
Ages 18–37 · Women only
University of Oklahoma · Sites in United States
Ages 18–110
By country, each count listing its studies:
A class of medicines: which ones, and the studies of each, are on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
229 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 40 · Phase 3 56 · Phase 4 84
First in 2000; this study’s year is marked. 11 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 900 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 229 interventional studies. Of the 168 that completed or were terminated, 70 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
55 of 229 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
12 of the studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03823534Phase 3St. Louis UniversityPost-Op Pain Control for Prophylactic Intramedullary Nailing. | 2027-03-31 |
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07571252University of Puerto RicoImpact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery | 2026-12 |
| NCT05919745Marquette UniversityPreemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft | 2026-12 |
| NCT06379425Northwell HealthImpact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries | 2027-01-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) plus acetaminophen or low dose opioids plus acetaminophen).
It is anticipated that the NSAID group will have superior clinical outcomes and fewer side effects when compared to the opioid group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Surgical teams will elect for one of the medications within the treatment arm to which the patient is randomized.
Drug: NSAID · Drug: Acetaminophen
Drug: Opioid · Drug: Acetaminophen
Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given: * Ibuprofen 600 milligram (mg) by mouth every six hours as needed for pain (10 doses) * Celecoxib 400 mg by mouth once then 200 mg every twelve hours as needed for pain (10 doses) * Naproxen 500 mg by mouth once then 250 mg by mouth every eight hours as needed for pain (10 doses)
Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given: * Oxycodone 5 mg by mouth every four to six hours as needed for pain, 10 doses * Morphine 7.5 mg by mouth every four to six hours as needed for pain, 10 doses * Hydromorphone 2 mg by mouth every four to six hours as needed for pain, 10 doses
Acetaminophen 1000 mg by mouth every 6 hours around the clock for the first three days after surgery then as needed thereafter (20 doses).
Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery
This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.
Time frame: 7 days post surgery
Safety outcome - number and severity of any adverse medication-related symptoms over 7 days post surgery
Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 7 days post surgery.
Time frame: 7 days post surgery
Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance v1.0 4a questionnaire
This is a 4 question survey in which participants will rate statements pertaining to quality of sleep. Participants will also rate sleep quality as very poor (5), poor (4), fair (3), good (2), or very good (1).
Time frame: 1 month post surgery
Clinically important adverse events
The study team will review charts for unplanned postoperative clinical interactions related to pain (patient messages, phone calls, non-routine clinic visits related to pain) and emergency room visits, hospitalizations, and 30-day complications after discharge measured using the American College of Surgeons' (ACS) National Surgical Quality Improvement Program (NSQIP) definitions.
Time frame: 180 days post surgery
Patient Global Impression of Change (PGIC)
The perception of improvement after treatment will be assessed by the patient global impression of change PGIC (range 0-7).
Time frame: up to 1 month after surgery
Quality of Recovery (QoR) 15
There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.
Time frame: 3 days post surgery
Quality of Recovery (QoR) 15
There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.
Time frame: 7 days post surgery
PROMIS Pain Interference 4a
This is a 4 question survey that assesses the degree to which pain interferes with various aspects of life. Items are scored on a 1 ("Not at all") to 5 ("Very much") scale with a range of 4 - 20. Higher scores indicate greater pain interference.
Time frame: 3 months
PROMIS Preference score 29+2 Profile v2.1
This is a 31 question survey that includes questions to evaluate each of 7 domains (physical function, anxiety, depression, fatigue, sleep disturbance, social functioning, and pain interference) using a 5- point Likert scale, as well as a single item to assess pain severity on a 0-10 scale as well as 2 questions for cognitive function. Higher scores are indicative of better health.
Time frame: 3 months
Substance use based on the Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) tool
This National Institute on Drug Abuse (NIDA) TAPS tool has part 1 (5 questions) and part 2 (possible 9 questions).
Time frame: 180 days post surgery
National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question
Time frame: 3 months
National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question
Time frame: 180 days
New prolonged opioid use
This will include greater or equal to 1 opioid prescription post-discharge between 4-180 days post discharge.
Time frame: days 4-180 post surgery
Chronic pain based on Brief Pain Inventory (BPI) pain intensity score at 180 days post surgery
One question survey in which the participants rate pain intensity recorded (0-10), ten being the worst.
Time frame: 180 days post surgery
Chronic pain based on Body Map
Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.
Time frame: 180 days post surgery
Acute pain based on The Michigan Body Map
Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.
Time frame: 7 days post surgery
Healthcare Utilization related to pain at 1 month
Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to one month later for the following three events: (1) postoperative clinical interactions related to pain in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.
Time frame: within 1 months after surgery
Healthcare Utilization related to pain at 6 months
Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to six months later related to pain for the following three events: (1) postoperative clinical interactions in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.
Time frame: within 6 months after surgery
Plan to share: Yes — Individual participant data that underlie the results of the trial that is not subject to restrictions based on data sharing agreements (e.g., prescription drug monitoring program data), after deidentification.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Anticipated summer of 2028 with no end date.
Access criteria: Investigators whose proposed use of the data has been approved by a review committee and the sponsor. The type of analyses will be for analyses related to aims in the proposal. Proposals may be submitted up to 36 months after data availability, after which data will be available in the data warehouse but without investigator support.
Started Feb 2023 (actual). Primary completion is estimated for Feb 2027, 48 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 48 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids